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Letters to the
Editor
Tubular heart valves
To the Editor:
Cox and associates1 recently presented in vitro
testing results on the 3F Aortic Bioprosthesis.
Unfortunately, Cox and colleagues chose
not to give authorship to any of the engi-
neers who performed this work, nor even
give them the courtesy of an acknowledge-
ment. Due to the lack of input from these
engineers, of whom I am one, the article
contains several technical and interpretive
errors that should be corrected. They are as
follows:
● The text gives the impression that a
laser micrometer was used to mea-
sure aortic chamber compliance dur-
ing flow testing. Those measurements
were actually made on valveless cham-
bers in a separate test system before
flow testing.
● The paper states, “Five milliliters of
corn starch was . . . injected into the
flow loop to act as an acoustic scat-
tering agent.” This is nonsensical
since laser-based flow visualization
does not employ acoustic scatter in
any way. The statement refers to a
technique used during in vitro Dopp-
ler studies and is presumably a “copy
and paste” error.
● Wear testing of the valve was not
conducted at 700 to 900 Hz as im-
plied. The test rate was 700 to 900
rpm, which is about 12 to 15 Hz.
● Wear testing was not conducted on
valve sizes 19-, 21-, 23-, 25-, and
27-mm valves, 2 of each size, as
stated. Testing was conducted on 19-,
25-, and 29-mm valves, 10 of each
size.
● The authors state, “This nonturbulent
flow was characteristic of . . . all valve
sizes . . ..” Since flow visualization
testing was only conducted on
19-mm valves, this is conjecture be-
ing stated as fact.
● The authors state, “The distribution of
stress on the leaflets of the 3F Aortic
Bioprosthesis shows the greatest de-
gree of stress to be in the belly of the
valve leaflets, with less stress at the
commissural posts (Figure 6).” This
statement is actually in direct contra-
diction to Figure 6. The figure clearly
shows the largest stresses to be along
the leaflet edge and at the commis-
sural attachment point.
These corrections are not intended to be
petty or esoteric. As the clinical use of the
3F aortic valve continues to grow, it is
important to have accurate literature re-
ports of how the valve has been tested, as
well as sound technical analyses of its per-
formance features. Rather than relying on
ill-conceived theories of “tubular” geome-
try or “form follows function,” the valve’s
excellent performance can be attributed to
more straightforward design features (ie,
the leaflet design, the small, unobstructive
sewing ring, the lack of rigid supports
structures, and the mechanical durability of
pericardium). An intellectually and scien-
tifically rigorous paper with a description
of these features and how they translate to
the observed performance would have been
much more useful.
Brian Biancucci
Ann Arbor, Mich
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Effectively treating ischemic mitral
regurgitation with chordal cuttling in
combination with ring annuloplasty
and a left ventricular reshaping
approach
To the Editor:
I read with great interest the case reported
by Yamamoto and colleagues1 in the Au-
gust 2005 issue of the Journal. In the arti-
cle the authors presented a patient in whom
they repaired chronic ischemic mitral re-
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gurgitation (IMR) by cutting the strut chor-
dae of the anterior mitral leaflet, and they
combined this approach with ring annulo-
plasty and left ventricular volume reduc-
tion surgery. The technique reported by
Yamamoto and colleagues is an effective
modality, but there are some concerns that
should be clarified. As stated previously,
IMR is a ventricular disease and not a
valvular disease. Although the tethering of
the mitral leaflet might play role in the
development of chronic IMR, it is not the
cause but rather the result of a pathophys-
iologic process. Chordal cutting increases
leaflet coaptation area by abolishing the
bending of the anterior mitral leaflet, but it
does not address all underlying mecha-
nisms of functional IMR. We also know
that the underlying cause of chronic IMR
might differ between individual patients.
Because the underlying mechanism might
differ between patient groups, the chordal
cutting technique might not have the same
effectiveness in all patients.
Lastly, I think that there was also a
misinterpretation of the successful result.
The authors used the combination of 3 dif-
ferent techniques, which addressed all the
underlying mechanisms, but only empha-
sized the importance of chordal cutting. I
believe that the successful result of this
surgical intervention could not be attrib-
uted to only the chordal cutting procedure.
Therefore the authors should comment on
how they draw such a result from the data
presented. Additionally, instead of chordal
cutting, I also believe that the main factor
for the disappearance of leaflet restriction
is the left ventricular volume reduction sur-
gery, which decreases the interpapillary
distance.
Murat Basaran, MD
Gata Military Training Hospital
Cardiovascular Surgery Service
Haydarpasa
Istanbul 34390
Turkey
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Reply to the Editor:
We thank Dr Basaran for raising important
questions concerning our report of chordal
cutting in combination with ring annuloplasty
and overlapping cardiac volume reduction
(OLCVR) operation, which is a new clinical
therapeutic approach for the treatment of
ischemic mitral regurgitation (IMR).
We think that IMR associated with myo-
cardial infarction and ischemic cardiomyop-
athy is a progressive disease. There is a
possibility of recurrence of IMR after the
operation because of the persistent left ven-
tricular (LV) remodeling. Therefore we paid
attention to not only a disappearance of mi-
tral regurgitation immediately after the oper-
ation but also to the long-term prevention of
IMR recurrence after surgical intervention.
We also think that LV plasty should
be able to not only reduce the LV volume but
also to correct the displaced papillary muscles
(PMs), and such LV plasty will thus contribute
greatly to reducing mitral tethering.
In some cases of IMR, chordal cutting
is a possible additional technique, depend-
ing on the patterns of chordal attachment,
and this technique will surely increase the
coaptation of the mitral leaflets in compar-
ison with LV plasty alone. In addition, we
expect this technique will also help to pre-
vent postoperative IMR recurrence.
The current surgical approach for IMR
mainly focuses on annular size reduc-
tion with an annuloplasty ring, which is
usually effective. However, mitral annulo-
plasty (MAP) is not a fundamental therapy
for IMR. Zhu and colleagues1 reported that
MAP causing anterior displacement of pos-
terior mitral annulus augments the tether-
ing of posterior mitral annulus with an im-
paired mobility and coaptation, and this
mechanism is also related to persistent
IMR after MAP. Therefore additional mi-
tral valve plasty will be necessary to reduce
such tethering.
Several methods related to the reduction
of the tethering of IMR have been reported.
Two approaches have been considered.
The first is to correct the displaced PMs,
and the second is to perform chordal cut-
ting. The reduction of the distance between
PMs by using PM imbrication and PM
sling and the reduction of the distance be-
tween the mitral annulus and PMs by relo-
cating the posterior PM and LV plication
can lead to a decrease in the degree of
tethering and the disappearance of MR. The
chordal cutting method, which cuts tethered
strut chordae, is a direct correction of the
tethering. However, whether chordal cutting
is possible depends on the attachment of strut
chordae to the anterior mitral leaflet. Only in
cases in which the bifurcated strut chordae
are attached to the leaflet edge and the mar-
ginal portion between the rough and clear
zone can chordal cutting spare the chorda
attached to the leaflet edge.
In this case, with severely dilatated and
dysfunctional LV after anterior myocardial
infarction, we thought it necessary to re-
duce the LV volume for end-stage ischemic
cardiomyopathy. The OLCVR operation is
thus considered to be an effective proce-
dure to correct the displaced PM dimen-
sions, but there is a risk that an LV volume
reduction sufficient to correct the PM dis-
placement might result in too small of an
LV volume. Matsui and coworkers2 re-
ported OLCVR with PM plication to en-
hance the remodeling effect of the ventricle.
We used 3 techniques to treat IMR in
this case. We also think that MAP and LV
plasty (OLCVR) contributed to our suc-
cessful results and that chordal cutting can
therefore reinforce mitral coaptation. We
hope that IMR recurrence can thus be pre-
vented long term after surgical intervention
by means of such a strategy.
Hiroyuki Yamamoto, MD
Ryuzo Sakata, MD
Department of Thoracic and Cardiovascular
Surgery
Kagoshima University
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Residual strain in the aorta
To the Editor:
We were excited to see yet another seminal
contribution to the literature on aortic an-
eurysmal disease arising from the labora-
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